Skip to Content

WPI 3331 (Bupropion Hydrochloride Extended-Release (XL) 150 mg)

Pill with imprint WPI 3331 is White, Round and has been identified as Bupropion Hydrochloride Extended-Release (XL) 150 mg. It is supplied by Watson Pharmaceuticals.

Bupropion is used in the treatment of major depressive disorder; depression; seasonal affective disorder; smoking cessation and belongs to the drug classes miscellaneous antidepressants, smoking cessation agents. Risk cannot be ruled out during pregnancy. Bupropion 150 mg is not a controlled substance under the Controlled Substances Act (CSA).

Images for WPI 3331

Bupropion hydrochloride extended-release (XL) 150 mg WPI 3331
Bupropion hydrochloride extended-release (XL) 150 mg WPI 3331  Front
Bupropion hydrochloride extended-release (XL) 150 mg WPI 3331  Back
Bupropion hydrochloride extended-release (XL) 150 mg WPI 3331

Bupropion Hydrochloride Extended-Release (XL)

Imprint
WPI 3331
Strength
150 mg
Color
White
Size
8.00 mm
Shape
Round
Availability
Prescription only
Drug Class
Miscellaneous antidepressants, Smoking cessation agents
Pregnancy Category
C - Risk cannot be ruled out
CSA Schedule
Not a controlled drug
Labeler / Supplier
Watson Pharmaceuticals
Inactive Ingredients
silicon dioxide, ethylcelluloses, hydroxypropyl cellulose (type h), methacrylic acid - ethyl acrylate copolymer (1:1) type a, microcrystalline cellulose, stearic acid, magnesium silicate, titanium dioxide, hydrochloric acid, triethyl citrate

Note: Inactive ingredients may vary.

Labelers / Repackagers

NDC CodeLabeler / Repackager
00591-3331 Watson Pharmaceuticals, Inc.
33261-0449 Aidarex Pharmacuticals, LLC (repackager)
54868-5927 Physicians Total Care Inc. (repackager)
53002-1495 Pharmedix (repackager)
33261-0680 Aidarex Pharmacuticals, LLC (repackager)

Get help with Imprint Code FAQs.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.